The Drug Enforcement Administration is backtracking on its decision to outlaw kratom apparently in part because the public doesn't want the ban.
Kratom is a plant that can help opioid addicts wean themselves off drugs. The DEA announced in August it would move the drug to the Schedule I list.
Schedule 1 drugs have a high potential for abuse and no proven medical use. The list includes marijuana, heroin, LSD and ecstasy.
But due to a lot of criticism, especially on Twitter and other social media, the DEA is considering reversing its decision, which is pretty surprising move.
One drug-policy researcher was quoted in the The Washington Post saying, "The DEA is not one to second-guess itself, no matter what the facts are."
But it wasn't just the internet that had a problem. When the DEA announced the ban, more than 50 U.S. representatives wrote a letter criticizing the decision. One researcher called it a "disservice to science."
So now, the agency will let the Food and Drug Administration weigh in.
A public comment period will also be open until Dec. 1. After that, the DEA could still decide to move the drug to Schedule I, enforce a temporary ban or could leave kratom unregulated like it was before.